Full genome screen for Alzheimer disease: Stage II analysis

Amanda Myers, Fabienne Wavrant De-Vrieze, Peter Holmans, Marian Hamshere, Richard Crook, Danielle Compton, Helen Marshall, David Meyer, Shantia Shears, Jeremy Booth, Dzanan Ramic, Heather Knowles, John C. Morris, Nigel Williams, Nadine Norton, Richard Abraham, Pat Kehoe, Hywel Williams, Varuni Rudrasingham, Francis RicePeter Giles, Nigel Tunstall, Lesley Jones, Simon Lovestone, Julie Williams, Michael J. Owen, John Hardy, Alison Goate

Research output: Contribution to journalArticle

179 Citations (Scopus)

Abstract

We performed a two-stage genome screen to search for novel risk factors for late-onset Alzheimer disease (AD). The first stage involved genotyping 292 affected sibling pairs using 237 markers spaced at approximately 20 cM intervals throughout the genome. In the second stage, we genotyped 451 affected sibling pairs (ASPs) with an additional 91 markers, in the 16 regions where the multipoint LOD score was greater than 1 in stage I. Ten regions maintained LOD scores in excess of 1 in stage II, on chromosomes 1 (peak B), 5, 6, 9 (peaks A and B), 10, 12, 19, 21, and X. Our strongest evidence for linkage was on chromosome 10, where we obtained a peak multipoint LOD score (MLS) of 3.9. The linked region on chromosome 10 spans approximately 44 cM from D10S1426 (59 cM) to D10S2327 (103 cM). To narrow this region, we tested for linkage disequilibrium with several of the stage II microsatellite markers. Of the seven markers we tested in family-based and case control samples, the only nominally positive association we found was with the 167 bp allele of marker D10S1217 (chi-square = 7.11, P = 0.045, df = 1).

Original languageEnglish (US)
Pages (from-to)235-244
Number of pages10
JournalAmerican Journal of Medical Genetics - Neuropsychiatric Genetics
Volume114
Issue number2
DOIs
StatePublished - Mar 8 2002
Externally publishedYes

Fingerprint

Chromosomes, Human, Pair 10
Alzheimer Disease
Genome
Chromosomes, Human, Pair 1
Linkage Disequilibrium
Microsatellite Repeats
Alleles

Keywords

  • Genome scan
  • Genome screen
  • Late-onset Alzheimer disease

ASJC Scopus subject areas

  • Genetics(clinical)
  • Cellular and Molecular Neuroscience
  • Psychiatry and Mental health

Cite this

Myers, A., De-Vrieze, F. W., Holmans, P., Hamshere, M., Crook, R., Compton, D., ... Goate, A. (2002). Full genome screen for Alzheimer disease: Stage II analysis. American Journal of Medical Genetics - Neuropsychiatric Genetics, 114(2), 235-244. https://doi.org/10.1002/ajmg.10183

Full genome screen for Alzheimer disease : Stage II analysis. / Myers, Amanda; De-Vrieze, Fabienne Wavrant; Holmans, Peter; Hamshere, Marian; Crook, Richard; Compton, Danielle; Marshall, Helen; Meyer, David; Shears, Shantia; Booth, Jeremy; Ramic, Dzanan; Knowles, Heather; Morris, John C.; Williams, Nigel; Norton, Nadine; Abraham, Richard; Kehoe, Pat; Williams, Hywel; Rudrasingham, Varuni; Rice, Francis; Giles, Peter; Tunstall, Nigel; Jones, Lesley; Lovestone, Simon; Williams, Julie; Owen, Michael J.; Hardy, John; Goate, Alison.

In: American Journal of Medical Genetics - Neuropsychiatric Genetics, Vol. 114, No. 2, 08.03.2002, p. 235-244.

Research output: Contribution to journalArticle

Myers, A, De-Vrieze, FW, Holmans, P, Hamshere, M, Crook, R, Compton, D, Marshall, H, Meyer, D, Shears, S, Booth, J, Ramic, D, Knowles, H, Morris, JC, Williams, N, Norton, N, Abraham, R, Kehoe, P, Williams, H, Rudrasingham, V, Rice, F, Giles, P, Tunstall, N, Jones, L, Lovestone, S, Williams, J, Owen, MJ, Hardy, J & Goate, A 2002, 'Full genome screen for Alzheimer disease: Stage II analysis', American Journal of Medical Genetics - Neuropsychiatric Genetics, vol. 114, no. 2, pp. 235-244. https://doi.org/10.1002/ajmg.10183
Myers, Amanda ; De-Vrieze, Fabienne Wavrant ; Holmans, Peter ; Hamshere, Marian ; Crook, Richard ; Compton, Danielle ; Marshall, Helen ; Meyer, David ; Shears, Shantia ; Booth, Jeremy ; Ramic, Dzanan ; Knowles, Heather ; Morris, John C. ; Williams, Nigel ; Norton, Nadine ; Abraham, Richard ; Kehoe, Pat ; Williams, Hywel ; Rudrasingham, Varuni ; Rice, Francis ; Giles, Peter ; Tunstall, Nigel ; Jones, Lesley ; Lovestone, Simon ; Williams, Julie ; Owen, Michael J. ; Hardy, John ; Goate, Alison. / Full genome screen for Alzheimer disease : Stage II analysis. In: American Journal of Medical Genetics - Neuropsychiatric Genetics. 2002 ; Vol. 114, No. 2. pp. 235-244.
@article{7af109b4f3ba4e0d819f1389461d6299,
title = "Full genome screen for Alzheimer disease: Stage II analysis",
abstract = "We performed a two-stage genome screen to search for novel risk factors for late-onset Alzheimer disease (AD). The first stage involved genotyping 292 affected sibling pairs using 237 markers spaced at approximately 20 cM intervals throughout the genome. In the second stage, we genotyped 451 affected sibling pairs (ASPs) with an additional 91 markers, in the 16 regions where the multipoint LOD score was greater than 1 in stage I. Ten regions maintained LOD scores in excess of 1 in stage II, on chromosomes 1 (peak B), 5, 6, 9 (peaks A and B), 10, 12, 19, 21, and X. Our strongest evidence for linkage was on chromosome 10, where we obtained a peak multipoint LOD score (MLS) of 3.9. The linked region on chromosome 10 spans approximately 44 cM from D10S1426 (59 cM) to D10S2327 (103 cM). To narrow this region, we tested for linkage disequilibrium with several of the stage II microsatellite markers. Of the seven markers we tested in family-based and case control samples, the only nominally positive association we found was with the 167 bp allele of marker D10S1217 (chi-square = 7.11, P = 0.045, df = 1).",
keywords = "Genome scan, Genome screen, Late-onset Alzheimer disease",
author = "Amanda Myers and De-Vrieze, {Fabienne Wavrant} and Peter Holmans and Marian Hamshere and Richard Crook and Danielle Compton and Helen Marshall and David Meyer and Shantia Shears and Jeremy Booth and Dzanan Ramic and Heather Knowles and Morris, {John C.} and Nigel Williams and Nadine Norton and Richard Abraham and Pat Kehoe and Hywel Williams and Varuni Rudrasingham and Francis Rice and Peter Giles and Nigel Tunstall and Lesley Jones and Simon Lovestone and Julie Williams and Owen, {Michael J.} and John Hardy and Alison Goate",
year = "2002",
month = "3",
day = "8",
doi = "10.1002/ajmg.10183",
language = "English (US)",
volume = "114",
pages = "235--244",
journal = "American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics",
issn = "1552-4841",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Full genome screen for Alzheimer disease

T2 - Stage II analysis

AU - Myers, Amanda

AU - De-Vrieze, Fabienne Wavrant

AU - Holmans, Peter

AU - Hamshere, Marian

AU - Crook, Richard

AU - Compton, Danielle

AU - Marshall, Helen

AU - Meyer, David

AU - Shears, Shantia

AU - Booth, Jeremy

AU - Ramic, Dzanan

AU - Knowles, Heather

AU - Morris, John C.

AU - Williams, Nigel

AU - Norton, Nadine

AU - Abraham, Richard

AU - Kehoe, Pat

AU - Williams, Hywel

AU - Rudrasingham, Varuni

AU - Rice, Francis

AU - Giles, Peter

AU - Tunstall, Nigel

AU - Jones, Lesley

AU - Lovestone, Simon

AU - Williams, Julie

AU - Owen, Michael J.

AU - Hardy, John

AU - Goate, Alison

PY - 2002/3/8

Y1 - 2002/3/8

N2 - We performed a two-stage genome screen to search for novel risk factors for late-onset Alzheimer disease (AD). The first stage involved genotyping 292 affected sibling pairs using 237 markers spaced at approximately 20 cM intervals throughout the genome. In the second stage, we genotyped 451 affected sibling pairs (ASPs) with an additional 91 markers, in the 16 regions where the multipoint LOD score was greater than 1 in stage I. Ten regions maintained LOD scores in excess of 1 in stage II, on chromosomes 1 (peak B), 5, 6, 9 (peaks A and B), 10, 12, 19, 21, and X. Our strongest evidence for linkage was on chromosome 10, where we obtained a peak multipoint LOD score (MLS) of 3.9. The linked region on chromosome 10 spans approximately 44 cM from D10S1426 (59 cM) to D10S2327 (103 cM). To narrow this region, we tested for linkage disequilibrium with several of the stage II microsatellite markers. Of the seven markers we tested in family-based and case control samples, the only nominally positive association we found was with the 167 bp allele of marker D10S1217 (chi-square = 7.11, P = 0.045, df = 1).

AB - We performed a two-stage genome screen to search for novel risk factors for late-onset Alzheimer disease (AD). The first stage involved genotyping 292 affected sibling pairs using 237 markers spaced at approximately 20 cM intervals throughout the genome. In the second stage, we genotyped 451 affected sibling pairs (ASPs) with an additional 91 markers, in the 16 regions where the multipoint LOD score was greater than 1 in stage I. Ten regions maintained LOD scores in excess of 1 in stage II, on chromosomes 1 (peak B), 5, 6, 9 (peaks A and B), 10, 12, 19, 21, and X. Our strongest evidence for linkage was on chromosome 10, where we obtained a peak multipoint LOD score (MLS) of 3.9. The linked region on chromosome 10 spans approximately 44 cM from D10S1426 (59 cM) to D10S2327 (103 cM). To narrow this region, we tested for linkage disequilibrium with several of the stage II microsatellite markers. Of the seven markers we tested in family-based and case control samples, the only nominally positive association we found was with the 167 bp allele of marker D10S1217 (chi-square = 7.11, P = 0.045, df = 1).

KW - Genome scan

KW - Genome screen

KW - Late-onset Alzheimer disease

UR - http://www.scopus.com/inward/record.url?scp=18244407351&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18244407351&partnerID=8YFLogxK

U2 - 10.1002/ajmg.10183

DO - 10.1002/ajmg.10183

M3 - Article

C2 - 11857588

AN - SCOPUS:18244407351

VL - 114

SP - 235

EP - 244

JO - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

JF - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

SN - 1552-4841

IS - 2

ER -